Thursday, November 27, 2025
HomeIndustriesBiotechnology

Biotechnology

Verastem Oncology Receives FDA Orphan Drug Designation for Avutometinib and Defactinib for the Treatment of Pancreatic Cancer

Verastem Oncology, a biopharmaceutical company committed to advancing new medicines for patients, announced that the U.S. Food and Drug Administration (FDA) has granted Orphan...

Amneal Receives U.S. FDA Approval for Potassium Phosphates Injection IV Bags

Amneal Pharmaceuticals, Inc. announced that it has received New Drug Application (“NDA”) approval from the U.S. Food and Drug Administration (FDA) for its new...

Windtree Therapeutics Provides Update on Istaroxime Clinical Development and Upcoming Clinical Trial Data

Windtree Therapeutics, Inc, a biotechnology company focused on advancing early and late-stage innovative therapies for critical conditions and diseases, announced an update of istaroxime...

MasterControl Announces the Appointment of Kelly Starman as Chief Marketing Officer

MasterControl, a leading provider of quality management and manufacturing software solutions, announced the appointment of Kelly Starman as Chief Marketing Officer (CMO). Starman brings to...

AbbVie Announces European Commission Approval of SKYRIZI for the Treatment of Adults with Moderately to Severely Active Ulcerative Colitis

AbbVie announced that the European Commission has approved SKYRIZI for the treatment of adult patients with moderately to severely active ulcerative colitis (UC) who...
0FansLike
0FollowersFollow
spot_img

Hot Topics